Cerebral Palsy Clinical Trial
This is a longitudinal, prospective, and open-label interventional study in a single center.
We will investigate the effect of single injection in each patient. This study was designed
to establish the clinical evidence for effect of botulinum toxin type a (Dysport,
abobotulinum toxin A) injection on changes in musculotendinous length and dynamics of
hamstring muscles during gait in children with spastic cerebral palsy walking with excessive
knee flexion.
Baseline data such as Modified Ashworth scale (MAS), Modified Tardieu scale (MTS), Gross
Motor Function Measures (GMFM), and Gross Motor Function Classification System (GMFCS) level
will be assessed. Gait analysis will be performed using a computerized gait analysis system
(VICON MX-T10 System with 6 infrared cameras, Oxford Metrics Inc., Oxford, UK) to measure the
kinematic data (angle of each joint) during the gait cycle. A trained investigator will place
14 reflective markers on the anterior and posterior superior iliac spine, the mid points of
the lateral femur, the lateral knee joint axis, the midpoints of the lateral tibia, the
lateral malleolus, and the dorsal foot between metatarsal heads 2 and 3. All subjects should
walk barefoot at a self-selected speed along an 8-meter path with the markers in place and
the motion will be captured with a 100-Hz sampling frequency. Force-plates (AMTI OR 6-5,
Advanced Mechanical Technology, Newton, MA, USA) under the path will record ground reaction
forces during the walking trials with a 1000-Hz sampling frequency, and joint moments will be
expressed as internal moments to counter the ground reaction forces. Data collection will
continue until the subject achieved at least 3 'clean' force-plate strikes. Kinematic and
kinetic data from successful trials will be used for statistical analysis. Video recording
will be done simultaneously from the front, rear, and side, with the 3D gait analysis.
Based on the evaluation including gait analysis, we will select the target muscles and inject
the toxin into the selected muscles of the spastic lower limb under the guidance of
ultrasonography or electrical stimulation. After BoNT-A injection, these children will be
evaluated after 1 month. Clinical data obtained in the baseline measurement will be assessed
again. Motion capture data will also be collected. Finally, clinical data of patients will be
collected 4 months after injection to identify the clinical improvement and side effects.
Motion capture data will be imported to OpenSim. We will generate an inverse kinematic
analysis of each subject using following procedure:
1. Scale the model to match the anthropometry of each subject. We will scale the dimensions
of the torso, pelvis, thigh, shank, and foot based on the relative distances between
pairs of markers measured experimentally and the corresponding markers in the model. The
muscle attachments will also be scaled with the segment.
2. Using a least-squares formulation, a set of desired joint angles for tracking,
consistent with each scaled model, based on the marker trajectories, joint constraints,
and joint angles from gait analysis will be computed.
3. The musculotendinous length of each muscle will be calculated based on the "lower limb
model 2010" by Arnold. This model adopted the wrapping surface to calculate the moment
arm and musculotendinous unit passage at each joint. This model is intended to be used
in research-graded kinematic analysis.
- Objectives <Primary objective>
1.To determine the changes of musculotendinous length of hamstrings after a single BoNT-A
injection during walking in children with spastic CP walking with excessive knee flexion
<Secondary objectives>
1. To determine the efficacy on gross motor function after BoNT-A injection
2. To determine the benefit on gait after BoNT-A injection
3. To determine the efficacy on spasticity after BoNT-A injection
4. To determine the kinematic change after BoNT-A injection
5. To determine the dynamic change after BoNT-A injection
6. To determine the treatment emergent adverse events following BoNT-A injection
- Subjects : total 32 children with cerebral palsy
- Intervention :
1. BoNT-A will be injected into two hamstring and/or gastrocnemius muscles under the guidance
of ultrasonography or electrical stimulation. 2. Maximal total dose and dose regimen for each
muscle would follow the recommendation of international consensus. A. Semitendinosus 5 to 7.5
units/kg of body weight B. Semimembranosus 5 to 7.5 units/kg of body weight C. Gastrocnemius
10 units/kg of body weight D. Maximal total dose per patient : unilateral injection 500
units, bilateral injection 1,000 units E. The dosage of two hamstring muscles will depend on
the severity of spasticity and gait abnormalities of children with CP
- Studies : 3D motion analysis, GMFM (gross motor function measure), GMFCS (gross motor
function classification system), MAS (modified Ashworth scale), MTS (modified Tardieu
scale)
- Evaluation plan : 1) pre-intervention, 2) post-4 weeks after intervention, 3) 16 weeks
after intervention
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05317234 -
Genetic Predisposition in Cerebral Palsy
|
N/A | |
Recruiting |
NCT05576948 -
Natural History of Cerebral Palsy Prospective Study
|
||
Completed |
NCT04119063 -
Evaluating Wearable Robotic Assistance on Gait
|
Early Phase 1 | |
Completed |
NCT03264339 -
The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy
|
N/A | |
Completed |
NCT05551364 -
Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy
|
N/A | |
Completed |
NCT03902886 -
Independent Walking Onset of Children With Cerebral Palsy
|
||
Recruiting |
NCT05571033 -
Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy
|
N/A | |
Not yet recruiting |
NCT04081675 -
Compliance in Children With Cerebral Palsy Supplied With AFOs
|
||
Completed |
NCT02167022 -
Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy
|
N/A | |
Completed |
NCT04012125 -
The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy
|
N/A | |
Enrolling by invitation |
NCT05619211 -
Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities
|
Phase 1 | |
Completed |
NCT04489498 -
Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
|
||
Completed |
NCT03677193 -
Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy
|
N/A | |
Completed |
NCT04093180 -
Intensive Neurorehabilitation for Cerebral Palsy
|
N/A | |
Completed |
NCT02909127 -
The Pediatric Eating Assessment Tool
|
||
Not yet recruiting |
NCT06377982 -
Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy
|
Phase 1 | |
Not yet recruiting |
NCT06007885 -
Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention.
|
N/A | |
Not yet recruiting |
NCT03183427 -
Corpus Callosum Size in Patients With Pineal Cyst
|
N/A | |
Active, not recruiting |
NCT03078621 -
Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy
|
Phase 1/Phase 2 | |
Completed |
NCT02849938 -
Evaluating the Value of Telehealth for Care of Children With Medical Complexity
|
N/A |